Evidence map›Paper›PMID 40278461›Full record

ArticleNanomaterials (Basel, Switzerland)2025

Apple Extract as an Effective Silver Reducer in the Synthesis of Ag Nanoparticles.

Anna Wasilewska, Anna Basa, Monika Zambrzycka, Izabela Swiecicka, Beata Kalska-Szostko

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna WasilewskaDoctoral School of University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.ORCID 0000-0001-8712-7482
Anna BasaFaculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.
Monika ZambrzyckaFaculty of Biology, University of Bialystok, Ciolkowskiego 1J, 15-245 Bialystok, Poland.ORCID 0000-0003-3354-4728
Izabela SwiecickaFaculty of Biology, University of Bialystok, Ciolkowskiego 1J, 15-245 Bialystok, Poland.ORCID 0000-0002-2750-9451
Beata Kalska-SzostkoFaculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.

Funding

EU POPW.01.03.00-20-004/11-00EU POPW.01.03.00-20-034/09-00of the Ministry of Education and Science in Poland 8636/E-342/SPUB/2021
6 · The paper itself

Abstract

Nowadays, there is a growing need to develop environmentally friendly procedures that reduce the use of toxic chemicals in synthesis. Green synthesis methods have an advantage over conventional chemical methods because they do not pollute the environment significantly. This has generated more interest in using readily available plants to create nanomaterials. In this work, silver nanoparticles were obtained through green chemistry using natural reducing agents present in apple extract. The research focused on optimizing the synthesis conditions to obtain predictable structures. The characterization of the nanoparticles was performed using transmission electron microscopy (TEM), dynamic light scattering (DLS), X-ray diffraction (XRD), UV-Vis spectroscopy, and infrared spectroscopy (IR). The achieved results led to the conclusion that the use of apple extract was suitable for obtaining homogenous and spherical silver nanoparticles at a wide range of core precursor concentrations and a variable pH. The diameter of the studied nanoparticles ranged from 6 to 22 nm. The nanoparticles obtained with apple extract were highly active against Gram-positive bacteria and fungus, but less active against Gram-negative bacteria. The development of nanotechnology in green chemistry processes will gradually increase with technological advances, being a key component in developing new synthesis processes for nano-object formation.

Indexed as

antimicrobial propertiesgreen synthesisnatural extractsphysicochemical characterizationsilver nanoparticles

Identifiers

PMID40278461
PMCPMC12029685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.